Physicians treating patients affected by nonmuscle-invasive bladder cancer (NMIBC) have
been in shock during the last six years since manufacturing restrictions on the production of …

Background The incidence of bladder cancer (BCa) is approximately four times higher in
men than in women. To develop effective BCa treatments, there is an urgent need to …

5. We conditionally recommend initial adjunctive corticosteroid treatment in all human
immunodeficiency virus (HIV)-negative patients with TB pericarditis. Routine use of …

Corosolic acid (CA) is a plant-derived terpenoid compound with many health benefits.
However, the anti-tumor effects of CA in bladder cancer remain unexplored. Here, we found …

Abstract Bacillus Calmette-Guerin (BCG) immunotherapy is a mainstay of adjunctive therapy
for non-muscle-invasive bladder cancer. The instillation of BCG in the upper urinary tract …

Background Existing chemotherapy and radiotherapy methods have drawbacks such as
high toxicity, high side effects, poor e cacy, and chemoresistance. Therefore, there is an …

Immunotherapy with BCG is an effective and widely used treatment for non-muscle-invasive
bladder cancer. BCG sepsis is a rare but life-threatening and frequently not a straightforward …

The nonspecific effects of BCG are not fully understood nevertheless,“trained immunity” and
“heterologous lymphocyte responses” have been suggested. For instance, intravesical BCG …

Background Intravesical instillation of bacillus Calmette–Guérin (BCG) as a treatment for
superficial bladder cancer rarely causes pulmonary complications. While published cases …

Objective: Rare coexistence of disease or pathology Background: Bladder cancer (BC) is the
second most common cancer involving the urinary system. In non-muscle-invading BC …